FGF13 and Myocardial fibrosis: Myocardial‐specific knockout and overexpression of FGF13 alleviated and exacerbated D‐galactose/Doxorubicin‐induced cardiac dysfunction, myocardial fibrosis, and aging characteristics in vivo, respectively.